7D Surgical Announces CE Mark Certification for Machine Vision Image Guided Spine Surgery

7D Surgical announced today that it has achieved CE Mark certification for its innovative Machine-vision Image Guided Surgery (MvIGS) system for spine surgery. This achievement clears the way for 7D Surgical to commence commercialization efforts of its spinal platform across the European market and additional global regions.

7D Surgical MvIGS System is the only approved image guidance system that utilizes a novel and proprietary camera-based technology, coupled with machine-vision algorithms to eliminate the long-standing frustrations with legacy surgical navigational platforms. The speed, accuracy, and efficiency of the MvIGS System, combined with a fundamentally streamlined surgical workflow provide significant economic value and harnesses the true potential of image guidance – all while enabling a safe, radiation-free surgical environment.

“We are extremely excited to achieve our CE Mark. With successful launches already underway in the United States, Canada, Australia, New Zealand and the Caribbean, we are eager to begin expanding the MvIGS technology into the European spine market,” said Beau Standish, Chief Executive Officer of 7D Surgical. “We are very proud of our team for accomplishing this important milestone and we are continuing our growth and expansion into international markets.”

Through 7D Surgical’s proprietary Flash™ Registration and Flash™ Fix technology, the platform is the only spine navigation system to offer true segmental registration. It utilizes visible light to not only allow spine surgeons to perform spinal registration in just seconds, but it also allows each vertebral body to be registered independently. As a result, system accuracy is not dependent on the position of the patient’s spine or patient movement that may occur over the course of the procedure. In addition, Flash™ Registration saves valuable operative time and eliminates intraoperative radiation exposure to the surgeon, staff, and patient.

“Accomplishing true segmental registration with our Flash™ Technology has had a tremendous impact on the safety and efficacy of the system, as it results in high navigational accuracy in mobile areas of the spine and complex anatomy,” said Brian Stuart, Chief Revenue Officer for 7D Surgical. “We are truly transforming what medical imaging and navigation is and what it can do to improve patient outcomes, while driving down healthcare costs.  We are extremely excited to introduce our novel 7D MvIGS system to European customers later this year.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.